Association of polymorphism of aromatase (CYP19A1) with the risk of complications in the application of hormonal contraception in women of reproductive age
An increasing number of hormonal contraceptives and their varying system effects on the body of a woman makes it necessary to personify their prescription and search for means of predicting their safety and tolerability. The article presents the research data and shows the various informative clinic...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Berlin A.V.
2016-10-01
|
| Series: | Гинекология |
| Subjects: | |
| Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/28547/pdf |
| _version_ | 1818857049509855232 |
|---|---|
| author | E V Ivanova V N Prilepskaya E A Mezhevitinova A E Donnikov D Yu Trofimov I G Nikitin |
| author_facet | E V Ivanova V N Prilepskaya E A Mezhevitinova A E Donnikov D Yu Trofimov I G Nikitin |
| author_sort | E V Ivanova |
| collection | DOAJ |
| description | An increasing number of hormonal contraceptives and their varying system effects on the body of a woman makes it necessary to personify their prescription and search for means of predicting their safety and tolerability. The article presents the research data and shows the various informative clinical predictors in the development of adverse reactions in the background. It was found that the most significant clinical predictors of occurrence of side effects and complications on the background of the use of the HC are the existence of gynecological diseases associated with menstrual cycles and poor portability of HC in history; an independent predictor of adverse effects on the background of the COC are chronic cholecystitis and dysfunction of the sphincter of Oddi; dynamics of lipid parameters, biochemical blood spectrum, as well as some parameters of hemostasis with the use of different variants of HC; genotype women polymorphic locus rs2414096 aromatase gene (CYP19A1) is a significant predictor of complications and side effects when using HC. |
| first_indexed | 2024-12-19T08:34:13Z |
| format | Article |
| id | doaj.art-caf55d06abd54b069854542c14c6f38b |
| institution | Directory Open Access Journal |
| issn | 2079-5696 2079-5831 |
| language | Russian |
| last_indexed | 2024-12-19T08:34:13Z |
| publishDate | 2016-10-01 |
| publisher | IP Berlin A.V. |
| record_format | Article |
| series | Гинекология |
| spelling | doaj.art-caf55d06abd54b069854542c14c6f38b2022-12-21T20:29:06ZrusIP Berlin A.V.Гинекология2079-56962079-58312016-10-011854925677Association of polymorphism of aromatase (CYP19A1) with the risk of complications in the application of hormonal contraception in women of reproductive ageE V Ivanova0V N Prilepskaya1E A Mezhevitinova2A E Donnikov3D Yu Trofimov4I G Nikitin5Moscow laser companyV.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian FederationV.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian FederationV.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian FederationV.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian FederationN.I.Pirogov Pediatrics Medical University of the Ministry of Health of the Russian FederationAn increasing number of hormonal contraceptives and their varying system effects on the body of a woman makes it necessary to personify their prescription and search for means of predicting their safety and tolerability. The article presents the research data and shows the various informative clinical predictors in the development of adverse reactions in the background. It was found that the most significant clinical predictors of occurrence of side effects and complications on the background of the use of the HC are the existence of gynecological diseases associated with menstrual cycles and poor portability of HC in history; an independent predictor of adverse effects on the background of the COC are chronic cholecystitis and dysfunction of the sphincter of Oddi; dynamics of lipid parameters, biochemical blood spectrum, as well as some parameters of hemostasis with the use of different variants of HC; genotype women polymorphic locus rs2414096 aromatase gene (CYP19A1) is a significant predictor of complications and side effects when using HC.https://gynecology.orscience.ru/2079-5831/article/viewFile/28547/pdfpersonalized approachtolerabilitysafetycontraceptionpharmacogeneticsaromatase |
| spellingShingle | E V Ivanova V N Prilepskaya E A Mezhevitinova A E Donnikov D Yu Trofimov I G Nikitin Association of polymorphism of aromatase (CYP19A1) with the risk of complications in the application of hormonal contraception in women of reproductive age Гинекология personalized approach tolerability safety contraception pharmacogenetics aromatase |
| title | Association of polymorphism of aromatase (CYP19A1) with the risk of complications in the application of hormonal contraception in women of reproductive age |
| title_full | Association of polymorphism of aromatase (CYP19A1) with the risk of complications in the application of hormonal contraception in women of reproductive age |
| title_fullStr | Association of polymorphism of aromatase (CYP19A1) with the risk of complications in the application of hormonal contraception in women of reproductive age |
| title_full_unstemmed | Association of polymorphism of aromatase (CYP19A1) with the risk of complications in the application of hormonal contraception in women of reproductive age |
| title_short | Association of polymorphism of aromatase (CYP19A1) with the risk of complications in the application of hormonal contraception in women of reproductive age |
| title_sort | association of polymorphism of aromatase cyp19a1 with the risk of complications in the application of hormonal contraception in women of reproductive age |
| topic | personalized approach tolerability safety contraception pharmacogenetics aromatase |
| url | https://gynecology.orscience.ru/2079-5831/article/viewFile/28547/pdf |
| work_keys_str_mv | AT evivanova associationofpolymorphismofaromatasecyp19a1withtheriskofcomplicationsintheapplicationofhormonalcontraceptioninwomenofreproductiveage AT vnprilepskaya associationofpolymorphismofaromatasecyp19a1withtheriskofcomplicationsintheapplicationofhormonalcontraceptioninwomenofreproductiveage AT eamezhevitinova associationofpolymorphismofaromatasecyp19a1withtheriskofcomplicationsintheapplicationofhormonalcontraceptioninwomenofreproductiveage AT aedonnikov associationofpolymorphismofaromatasecyp19a1withtheriskofcomplicationsintheapplicationofhormonalcontraceptioninwomenofreproductiveage AT dyutrofimov associationofpolymorphismofaromatasecyp19a1withtheriskofcomplicationsintheapplicationofhormonalcontraceptioninwomenofreproductiveage AT ignikitin associationofpolymorphismofaromatasecyp19a1withtheriskofcomplicationsintheapplicationofhormonalcontraceptioninwomenofreproductiveage |